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ABSTRACT 
Reproductive function is often impaired during chemotherapy and currently there is no universally approved drug/supplement 
that can effectively protect the testis from cellular assault due to chemotherapeutic agent such as doxorubicin (dox). This study 
was designed to investigate the efficacy of D-Ribose-L-Cysteine rich supplement, Cellgevity™ (cgt), in ameliorating some 
doxorubicin-induced testicular damage in Sprague-Dawley rats. At the end of the study, biochemical assays and sperm 
epididymal parameters analysis were done. Our results show that simultaneous administration of cgt and doxorubicin has 
ameliorative effect on the testis when compared to pre-treatment or post-treatment with cgt. Significant increase in testosterone, 
sperm concentration, progressive motility and significant decrease in immotility were observed in the cellgevity treated group. 
Also, simultaneous administration of cgt with dox reduced lipid peroxidation and boosted only glutathione level in testicular 
tissues. Nevertheless, pre-treatment or post-treatment with cgt did not play a significant role in modulating sperm parameters, 
hormones and tissue oxidative stress level. This result reveals that cellgevity has testiculo-protective effect against doxorubicin 
administration.  
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INTRODUCTION 
 
Chemotherapy is one of the available treatments for cancer. It 
involves the use of chemicals (anticancer drugs) to target 
cancerous or rapidly dividing cells (Bagnyukova et al., 2010). 
One of the most popular and most active chemotherapeutic 
drugs is doxorubicin (dox) (Kumar et al., 2014). It is an 
anthracycline antibiotic closely related to the natural product 
daunomycin and like all anthracycline it works by 
intercalating DNA and remains one of the most potent 
antineoplastic drugs (Awasthi et al., 2003; Carvalho et al., 
2009). It is, therefore, common to use dox in the treatment of 
solid tumours and haematological malignancies, including 
breast, bile ducts, prostate, uterus, ovary, oesophagus, 
stomach and liver tumours, childhood solid tumours, 
osteosarcoma and soft tissue sarcoma, Kaposi’s sarcoma as 
well as acute myeloblastic and lymphoblastic leukaemia and 
Wilm’s tumour (Danesi et al, 2002; O’Shaugnessy et al, 2003; 
Gruber et al., 2004; Petrioli et al., 2008). The core 
characteristics of anthracyclines include the production of 
reactive oxygen species and it has been shown that these 
molecular characteristics are double-edged sword acting not 
only on neoplastic cells but also on multiple cellular targets 
throughout the body (Cummings et al., 1991; Cappetta et al., 
2017). Therefore, the mechanism of action of dox involves its 
oxidation to semiquinone, which is an unstable metabolite that 
is converted back to dox in a process that releases reactive 
oxygen species (Thorn et al., 2011).  
 Testicular dysfunction is amongst the most common 
long-term side effect of chemotherapy in men. This is because 
the testis, being a rapidly dividing organ in the body, is an easy 
target for cytotoxic chemotherapeutic drugs.  Thus, male 
individuals undergoing chemotherapy stand the risk of 
temporary, long-term or permanent gonadal damage (Traila et 
al., 2018). This, therefore, has raised concerns about the 
reproductive health of surviving patients since they eventually 
are at risk of persistent impaired spermatogenesis and 
infertility (Ishikawa et al., 2004; Pectasides et al., 2004; 
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Bieber et al., 2006).  Studies have reported that dox induces 
significant decline in testicular weight, sperm count, serum 
testosterone and increases in serum lactate dehydrogenase and 
increases lipid peroxidation in the testis (Quiles et al., 2002; 
Patil et al, 2009, Saalu et al., 2010).   
 Cellgevity™ (cgt), made up of mainly riboceine™ which 
contains cysteine molecularly coated with ribose. Following 
intestinal absorption, the ribose is transported into the cell 
where the cysteine is decoupled and used in the synthesis of 
gluthatione (Max International, 2017). Other constituents of 
cgt include alpha lipoic acid, broccoli seed extract, turmeric 
root extract, resveratrol, grape seed extract, quercetin, milk 
thistle, vitamin c, selenomethione, cordyceps, black pepper, 
and aloe extract (Max International, 2017). Recent studies 
have indicated that cgt may play some roles in lowering 
oxidative stress level in tissues (Falana et al., 2017). Since dox 
has been shown to increases lipid peroxidation in the testis 
(Patil et al, 2009; Saalu et al., 2010), the aim of this study was 
to determine whether glutathione-promoting D-Ribose-L-
Cysteine-rich supplement as an adjunct to dox can  prevent 
and/or ameliorate the effect of dox on testicular 
morphofunctional integrity in Sprague-Dawley rats. 
 
 
MATERIALS AND METHODS 
 
Cellgevity™ was purchased from Max International, Ikeja, 
Lagos, Nigeria while doxorubicin was purchased from 
Bernados Pharmacy, Lagos State, Nigeria. Experimental 
animals used for this research were obtained from the Animal 
House of College of Medicine of the University of Lagos, 
Lagos State, Nigeria. They were kept in the Animal House of 
the Department of Anatomy, College of Medicine, University 
of Lagos, Nigeria. Animals were allowed access to rat chow 
and water ad libitum under normal laboratory conditions of 
12:12 light / dark cycle. 
 
Experimental Design: At the beginning of the experiment, 30 
male Sprague-Dawley rats (180-200 grams) were divided into 
six groups (n= 6 rats/group). Control group consist of animals 
that were given distilled water. The dox group was 
administered 1.8 mg/kg of dox only for 14 days. The cgt group 
was administered, based on human dose equivalent (Nair and 
Jacob, 2016), 150 mg/kg cgt only for 14 days. The dox+cgt 
group was administered 1.8 mg/kg body weight of dox and 
150 mg/kg body weight of cgt simultaneously for 14 days. The 
1 week dox+cgt group was administered 1.8 mg/kg body 
weight of dox the first week and 150 mg/kg of cgt the second 
week while the 1 week cgt+dox was administered 150 mg/kg 
of cgt the first week and 1.8mg/kg  body weight of dox the 
second week. All administrations for the different durations 
were done orally.  
 
Animal Euthanasia, Samples Collection and Hormone 
Assay: At the end of administrations, animals were sacrificed 
by cervical dislocation. On each animal, ventral abdominal 
incision was made following which blood was collected, 
through cardiac puncture, into anticoagulant-free sample 
bottles and centrifuged at 3000rpm for 15 minutes to obtain 
serum for hormonal assay of testosterone (TT) and estradiol 
(E2) using ELISA kit obtained from Accubind Inc (USA). 
Manufacturer’s instructions that accompanied assay kits were 
strictly adhered to. The left testis was homogenized in cold 
phosphate buffer and centrifuged at 3000rpm. The supernatant 
was collected into plain sample bottle, stored at -20oC and was 
later used for hormonal assay and oxidative stress studies.  
 
Semen Analysis Epididymal Sperm Count: Sperm count 
was done as previously described by Latchoumycandane et al. 
(2002). Briefly, 0.1 mL sample of semen was placed in 0.9 mL 
normal saline for sperm cells to swim out in the petri-dish. It 
was well shaken and the sample was taken to a counting 
chamber (improved Nuebauer hemocytometer; (Deep 1/10 m; 
LABART, Munich, Germany). After the sperm cells have 
settled on the grid, it was then viewed under the microscope 
and spermatozoa in five squares were counted. The number of 
sperms counted in five squares was multiplied by dilution 
factor and 0.05 and 106 to determine the number of sperm per 
mL.  
 
Determination of Sperm Motility: To assess motility, a drop 
of epididymal fluid was delivered onto a glass slide such that 
the spermatozoa were evenly distributed, covered by a 22x22 
mm cover slip and examined under the light microscope at a 
magnification of x100 while several fields were evaluated. 
Sperm motility was classified as progressive motile, non-
progressive motile or immotile. After assessing different 
microscopic fields, the relative percentage of motile sperm 
was estimated and reported to the nearest 5% using the 
subjective determination of motility (WHO, 2010). 
 
Determination of Tissue Lipid Peroxidation and 
Antioxidant Enzymes activities: Malondialdehyde (MDA) 
was used as a proxy index for lipid peroxidation in testicular 
tissue homogenate and determined using the method of 
Mihara and Uchiyama (1978). It is based on the interaction of 
MDA with thiobarbituric acid (TBA) to form a pink complex 
and absorbance read at 535nm. Glutathione (GSH) level was 
determined in tissue PBS sample based on the reaction of 
Ellman’s reagent 5,5’ dithiobis (2-nitrobenzoic acid) DNTB) 
with the thiol group of GSH (Ellman, 1959). The level of 
activity of superoxide dismutase (SOD) was determined by its 
ability to inhibit the auto-oxidation of epinephrine determined 
by the increase in absorbance at 320nm. The reaction was 
carried out in 0.05N HCL (Sun and Zigman, 1978). Catalase 
(CAT) activity was measured in the tissue PBS samples by the 
method of Aebi (1984), which is based on the exponential 
disappearance of H2O2 by the action of catalase contained in 
the examined samples. 
 
Statistical Analysis 
The data were analyzed using one-way analysis of variance 
(ANOVA) followed by Bonferroni’s Multiple Comparison 
Test. Data are expressed as mean ± standard error of mean 
(SEM).  Graphpad Prism 5 was used to determine the 
statistical significance of the data. Values were considered 
significant at p<0.05. 
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RESULTS 
 
Sperm Parameters 
As shown in Figure 1, there was a significant decrease in 
sperm concentration in dox-treated group compared with 
control whereas cgt-treated group showed no significant 
difference compared with control. 1 WK dox+cgt and 1WK 
cgt+dox treated groups also showed significant decrease in 
sperm concentration compared with control. However, 
dox+cgt treated group showed significant increase in sperm 
concentration when compared to the dox, 1 WK dox+cgt and 
1WK cgt+dox treated rats. In Figure 1b, the percentage of non-
progressive motility was significantly increased in dox-, 1WK 
dox+cgt-, and 1WK cgt+dox- treated groups compared with 
control. Also, there was a significant decrease in non-
progressive motility of cgt treated group when compared with 
control and dox+cgt. In Figure 1c, there was a significant 
decrease in progressive motility in dox treated group 
compared with control group whereas cgt-treated group 
showed no significant difference compared with control. 
When compared to the control group, 1WK dox+cgt, 1WK 
cgt+dox showed significant decrease in progressive motility. 
However, there was a significant increase in progressive 
motility in dox+cgt treated rats when compared with dox, 
1WK dox+cgt, 1WK cgt+dox group. In Figure 1d, sperm 
immotility was significantly increased in dox-, dox+cgt-, and 
1 WK cgt+dox- treated groups whereas there was a significant 
decrease in immotility of cgt treated group when compared 
with control and cgt group. 
 
 
 
 
Figure 1 
Comparison of sperm parameters between experimental groups. ⃰ shows significance difference compared with control and cgt; ** indicates 
significance difference compared with control and dox at p<0.05; λ indicates significance difference compared with dox, dox+cgt, 1 wk cgt + 
dox at p<0.05. Dox= Doxorubicin, cgt= CellgevityTM. 1Wk dox + cgt means animals receive dox for one week before treatment with cgt for 
another one week. 1Wk cgt + dox means animals were treated with cgt for one week before administration of dox for another one week. 
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Figure 2 
Comparison of Testicular Testosterone, Serum Testosterone and Serum Estradiol concentration between experimental groups.   ⃰ indicates 
significant difference compared with control at p<0.05; λ shows statistical significance between cgvt group and other treated groups at p <0.05. 
Dox= Doxorubicin, cgt= CellgevityTM. 1Wk dox + cgt means animals receive dox for one week before treatment with cgvt for another one 
week. 1Wk cgt + dox means animals were treated with cgt for one week before administration of dox for another one week. 
 
Concentrations of Testosterone and Estradiol: Serum 
testosterone following treatment with dox and cgt is shown in 
Figure 2a. Serum concentration of testosterone significantly 
reduced in dox- treated group compared with control group. 
Similarly, there was significant reduction of serum 
testosterone in dox+cgt, 1WK dox+cgt, and 1WK cgt+dox 
groups compared with control. However, significant increase 
in serum testosterone (TT) of the cgt treated group was 
observed when compared to the control group. Testicular 
testosterone following treatment with dox and cgt is shown in 
Figure 2b. There was a significant reduction in testicular TT 
of dox, 1WK dox+cgt, 1WK cgt+dox treated groups when 
compared with the control group. However, dox+cgt group 
showed no significant reduction in testicular TT compared 
with control. In cgt treated group, testicular TT increased 
significantly when compared with control. In Figure 1c, there 
was no significant difference in the level of serum estradiol of 
dox, cgt, 1WK dox+cgt, 1WK cgt+dox compared with the 
control group.  
 
Lipid Peroxidation and Antioxidant Enzymes Activities 
Lipid peroxidation and antioxidant enzymes activities in 
testicular tissue are shown in Figure 3. There was a significant 
increase in MDA level of dox and 1WK cgt+dox-treated 
groups compared with control. There was no significant 
difference in the MDA level of dox+cgt, 1WK dox+cgt, and 
cgt-treated groups when compared with control (Figure 3a).  
In Figure 3b, the level of GSH was significantly reduced in 
dox-treated group compared with control. However, GSH 
level significantly increased in dox+cgt treated group when 
compared to the control group. While there is no significant 
difference in GSH between the 1WK dox+cgt and 1WK 
cgt+dox treated groups, there is a significant decrease in GSH 
in dox+cgt, 1WK dox+cgt, 1WK cgt+dox when compared to 
cgt-treated group. In addition, there is a significant increase in 
GSH level of dox+cgt when compared with 1wk cgt+dox.  
In Figure 3c, there was a significant decrease in catalase in 
dox, dox+cgt, 1WK dox+cgt, 1WK cgt+dox when compared 
to cgt and control group. However, there is a significant 
increase in the CAT levels of the control and cgt treated group 
when compared to dox, dox+cgt, 1 WK dox+cgt, 1WK 
cgt+dox treated group.  
 In Figure 3d, there was no significant difference in the 
level of SOD in the control when compared to dox, cgt, 1WK 
dox+cgt, 1WK cgt+dox treated group 
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Figure 3 
Malondialdehyde concentrations and antioxidant enzymes activities between the experimental groups. * indicates statistically significant 
diffences compared with control and cgt treated groups while γ  shows statistically significant diffences compared with dox and λ indicates 
statistically significant diffences compared with dox+cgt and 1 Wk dox+cgt  (p <0.05). Dox= Doxorubicin, cgt= CellgevityTM. 1Wk dox + 
cgt means animals receive dox for one week before treatment with cgt for another one week. 1Wk cgt + dox means animals were treated with 
cgt for one week before administration of dox for another one week 
 
 
DISCUSSION 
 
The results of this investigation reveal that supplementation 
with cgt might be a beneficial adjunct therapy for men 
receiving dox medication against cancer. In the present study, 
semen parameters improved significantly in the group that 
received cgt simultaneously with dox. Specifically, dox+cgt-
treated group showed significant increase in sperm 
concentration when compared to the group treated with dox 
only, the group treated with dox for one week followed by 
another week of cgt administration, and the group treated with 
cgt for one week before administration of dox another week. 
This implies that cgt can boost sperm concentration; when 
administered simultaneously with dox, it minimizes the 
deleterious effect of dox on the sperm concentration when 
compared to the groups that were administered with cgt a 
week before or a week after. In addition, there was a 
significant increase in progressive motility in cgt group when 
compared to the dox, 1WK dox+cgt, 1WK cgt+dox. This 
shows that cgt increases progressive motility in the animal and 
also modulates progressive motility in dox challenged 
animals. The negative effect of dox on semen parameters 
observed in this study is consistent with the findings of 
previous investigations (Saalu et al., 2010; Badkoobeh et al., 
2013, Uyeturk et al., 2014). Overall, simultaneous 
administration of dox and cgt proves to yield better results of 
improving sperm motility when compared to the other 
treatment groups that were administered cgt a week before and 
after dox.  
 From this study, the mechanism through which cgt 
improves semen parameters appears to be mediated through 
increase steroidogenesis and boosting testicular anti-oxidant 
defense system. There is a significant increase in testicular TT 
in dox+cgt compared with dox, 1WK dox+cgt, 1WK cgt+dox- 
treated groups. But there was no significant increase in serum 
levels of TT in all the treated groups except cgt only group 
(Figure 2). This suggests that cgt can attenuate dox’s 
interference in Leydig cells’ testosterone production capacity. 
On estradiol levels, however, there was no significant 
difference in all the groups indicating that neither dox nor cgt 
has major interference with estradiol steroidogenesis. 
Elevated level of estradiol has been shown to impede testicular 
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function (Schulster et al., 2016); however, our present 
findings indicate that the mechanism of dox testicular insult is 
independent of estradiol level. 
 The impact of cgt on testicular steroidogenesis may 
derive from reduced level of free radicals that may otherwise 
impede testosterone elaboration by Leydig cells resulting in 
many more spermatogenic cells surviving to spermatozoa 
stage. Studies have shown that free radical generation, which 
is a natural by-product of testicular cellular activity, reduces 
spermatogenic efficiency (Yokoi and Mayi, 2004; Pranhalatan 
et al., 2005; Attesahin et al., 2006, Priestman, 2008). With the 
current work, it might be possible to increase sperm 
production in apparently normal individual by lowing 
testicular free radical contents. 
 Furthermore, the activities of oxygen free radical, 
superoxide radical and oxidative stress have been strongly 
accepted as essential factors in the pathogenesis of dox-
induced cytotoxicity (Chularojmontri et al., 2005, Prahalatan 
et al., 2005; Saalu et al., 2010). This is confirmed in this study 
as significant elevation of MDA was observed in dox only 
group which provides evidence of increased lipid peroxidation 
in the testis of dox challenged animals. GSH exhibits the first 
line of antioxidant defence and primarily regulates redox 
status in cells (Schafer and Buettner, 2001; Suntres, 2011). 
GSH is involved in scavenging hydroxyl radical and 
detoxification of hydrogen peroxides and lipid peroxides 
through the action of glutathione peroxidase (Kern and 
Kehrer, 2005). In this present study, concomitant 
administration of cgt with dox significantly improved GSH 
level in comparison with sole administration of dox (Figure 3) 
suggesting that cgt has the capacity to boost cellular GSH 
production in the presence of pro-oxidant-generating dox. 
However, while animals that were treated with cgt either one 
week before or after dox administration exhibited higher GSH 
levels than the dox group; their GSH levels did not attain that 
of the control’s. This is in accordance with a previous study 
which shows that dox reduces GSH levels in the testis (Saalu 
et al., 2010). The significant increase in GSH level of cgt+dox 
group compared with 1 WK dox+cgt and 1WK cgt+dox 
implies that simultaneous administration of cgt with dox is the 
most effective way of preventing significant depletion of GSH 
not pre- or post-treatment. But cgt was unable to prevent dox-
induced GSH depletion in the animals that where administered 
one week before dox and one week after dox. This is 
responsible for the elevation in MDA levels observed in these 
groups.  
 SOD and CAT are important scavengers of superoxide 
ion and hydrogen peroxide. These two enzymes prevent the 
generation of hydroxyl radical and protect cellular 
constituents from oxidative damage (Sivaraj et al., 2011). 
SOD is involved in the rapid dismutation of superoxide anion 
(O2-) to hydrogen peroxide (H2O2). The H2O2 generated from 
this dismutation process is also a powerful membrane 
penetrating oxidant which has to be rapidly removed from the 
cell. The elimination of H2O2 in the cell can be handled by 
catalase in reactions that produce water and molecular oxygen 
(Trachootham et al., 2008). In this study, cgt had no 
significant impact on the activities of SOD and CAT. In all the 
groups treated with dox, the activity of catalase was 
significantly reduced while the activity of SOD remained 
unaffected. This suggests that neither dox nor cgt affected 
SOD levels remarkably.  The incidence of chemotherapy-
induced elevation in tissue oxidant level has been well 
reported as a major mechanism by which chemotherapy agents 
destroy cancer cells; and in the process normal cells become 
collaterally damaged (Priestman, 2008). Spermatozoa 
constitute one of the body cells that are most likely to undergo 
dox-induced oxidative damage. This was prevented by cgt as 
many more spermatogenic cells survive to spermatozoa stage.  
 In conclusion, this study demonstrates dox impairs 
spermatogenesis and testicular steroidogenesis by increasing 
cellular level of pro-oxidants evident by elevated MDA level. 
However, concomitant administration of cgt with dox 
suppresses dox-induced elevated oxidative stress and 
improved sperm parameters. This indicates that cgt possesses 
significant testiculoprotective effects, especially during 
simultaneous administration of dox. Since the testis is 
susceptible to chemotherapy-induced oxidative damage, the 
current investigation provides evidence that may open a new 
pathway for the management of cancer in such a way that 
allows for the preservation of male reproductive functions. 
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